AusPAR: Influenza virus haemagglutinin inactivated split influenza vaccine

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

31 March 2014
AusPAR Details
AusPAR
AusPAR: Influenza virus haemagglutinin inactivated split influenza vaccine (pdf, 950 KB)
AusPAR: Influenza virus haemagglutinin inactivated split influenza vaccine (docx, 1 MB)
Attachment: Product Information: Influenza virus haemagglutinin inactivated split influenza vaccine (pdf, 148 KB)
Attachment: Product Information: Influenza virus haemagglutinin inactivated split influenza vaccine (docx, 49 KB)
Attachment: Extract from Clinical Evaluation Report: Influenza virus haemagglutinin inactivated split influenza vaccine (pdf, 2 MB)
Attachment: Extract from Clinical Evaluation Report: Influenza virus haemagglutinin inactivated split influenza vaccine (docx, 3 MB)
Active Ingredient
Influenza virus haemagglutinin inactivated split influenza vaccine
Product Name
Fluarix Tetra
Sponsor
GlaxoSmithKline Australia Pty Ltd
Submission Number
PM-2012-02287-3-2
Submission Type
New chemical/biological entity
Decision
Approved
AusPAR Date
6 February 2014
Publication Date

31 March 2014
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/825